156 related articles for article (PubMed ID: 15211251)
21. [Finally a highly specific test for the differential diagnosis of dyspnea: BNP determination].
Faggiano P; D'Aloia A; Dei Cas L
Monaldi Arch Chest Dis; 2002 May; 58(1):47-50. PubMed ID: 12693069
[TBL] [Abstract][Full Text] [Related]
22. Effect of renal failure on N-terminal Pro-Brain natriuretic peptide in patients admitted to emergency department with acute dyspnea.
Çolak A; Çuhadar S; Gölcük B; Gölcük Y; Özdoğan Ö; Çoker I
Anadolu Kardiyol Derg; 2014 Sep; 14(6):519-24. PubMed ID: 25233498
[TBL] [Abstract][Full Text] [Related]
23. Evolution of B-type natriuretic peptide in evaluation of intensive care unit shock.
Bhalla V; Bhalla MA; Maisel AS
Crit Care Med; 2004 Aug; 32(8):1787-9. PubMed ID: 15286561
[No Abstract] [Full Text] [Related]
24. Natriuretic peptide testing in emergency settings.
Ordonez-Llanos J; Merce-Muntanola J; Santalo-Bel M
Clin Chem Lab Med; 2008; 46(11):1543-9. PubMed ID: 19012518
[TBL] [Abstract][Full Text] [Related]
25. [Comment on the study by H.G. Schneider et al..: "B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea"].
Müller Ch
Praxis (Bern 1994); 2009 Jul; 98(15):835-6. PubMed ID: 19642067
[No Abstract] [Full Text] [Related]
26. [Comment on the study by H.G. Schneider et al.: "B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea"].
Krause M
Praxis (Bern 1994); 2009 Jul; 98(15):833-4. PubMed ID: 19642066
[No Abstract] [Full Text] [Related]
27. B-type natriuretic peptide in heart failure.
Colli A; Fraquelli M; Conte D
N Engl J Med; 2002 Dec; 347(24):1976-8; author reply 1976-8. PubMed ID: 12477952
[No Abstract] [Full Text] [Related]
28. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].
Dahlström U; Alehagen U
Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036
[No Abstract] [Full Text] [Related]
29. [Usefulness of NTproBNP in the emergency management of patients with severe dyspnea and an uncertain heart failure diagnosis].
Pascual Figal DA; Cerdán Sánchez MC; Noguera Velasco JA; Casas Pina T; Muñoz Gimeno L; García Rodríguez R; Ruipérez Abizanda JA; Martínez Hernández P; Valdés Chávarri M
Rev Esp Cardiol; 2005 Oct; 58(10):1155-61. PubMed ID: 16238983
[TBL] [Abstract][Full Text] [Related]
30. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
[TBL] [Abstract][Full Text] [Related]
31. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL;
Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961
[TBL] [Abstract][Full Text] [Related]
32. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study.
Januzzi JL; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Rivers EJ; Walters EL; Gaggin HK;
J Am Coll Cardiol; 2018 Mar; 71(11):1191-1200. PubMed ID: 29544601
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
[TBL] [Abstract][Full Text] [Related]
34. [The circulating NTproBNP level, a new biomarker for the diagnosis of heart failure in patients with acute shortness of breath].
Bayés-Genís A
Rev Esp Cardiol; 2005 Oct; 58(10):1142-4. PubMed ID: 16238980
[No Abstract] [Full Text] [Related]
35. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
[TBL] [Abstract][Full Text] [Related]
36. NTproBNP--a role to play.
Obel IW
S Afr Med J; 2006 Apr; 96(4):256. PubMed ID: 16670781
[No Abstract] [Full Text] [Related]
37. Advantages to transforming the receiver operating characteristic (ROC) curve into likelihood ratio co-ordinates.
Fosgate GT
Stat Med; 2005 Apr; 24(8):1287-8; author reply 1288. PubMed ID: 15765500
[No Abstract] [Full Text] [Related]
38. [The place of natriuretic peptide in the diagnosis of heart failure].
Mahé I
Presse Med; 2003 Jan; 32(1):9. PubMed ID: 12610389
[No Abstract] [Full Text] [Related]
39. Emergency thoracic ultrasound in the differentiation of the etiology of shortness of breath (ETUDES): sonographic B-lines and N-terminal pro-brain-type natriuretic peptide in diagnosing congestive heart failure.
Liteplo AS; Marill KA; Villen T; Miller RM; Murray AF; Croft PE; Capp R; Noble VE
Acad Emerg Med; 2009 Mar; 16(3):201-10. PubMed ID: 19183402
[TBL] [Abstract][Full Text] [Related]
40. B-type natriuretic peptide - a biomarker for all seasons?
Mark DB; Felker GM
N Engl J Med; 2004 Feb; 350(7):718-20. PubMed ID: 14960748
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
